Osteoclast lineage and function.
暂无分享,去创建一个
[1] T. Iwamoto,et al. Three Na+/Ca2+ exchanger (NCX) variants are expressed in mouse osteoclasts and mediate calcium transport during bone resorption. , 2007, Endocrinology.
[2] H. Väänänen,et al. Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. , 1997, Journal of cell science.
[3] J. Tuukkanen,et al. Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts , 1990, The Journal of cell biology.
[4] W. Boron,et al. Colony-stimulating factor-1 increases osteoclast intracellular pH and promotes survival via the electroneutral Na/HCO3 cotransporter NBCn1. , 2007, Endocrinology.
[5] B. Gelb,et al. Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency , 1996, Science.
[6] P. Lehenkari,et al. Removal of osteoclast bone resorption products by transcytosis. , 1997, Science.
[7] T. Martin,et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[8] T. Hentunen,et al. Characterization of Circulating Human Osteoclast Progenitors: Development of In Vitro Resorption Assay , 2005, Calcified Tissue International.
[9] O. Jaillon,et al. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. , 2000, Bone.
[10] D. Wang,et al. Identification of the type II Na(+)-Pi cotransporter (Npt2) in the osteoclast and the skeletal phenotype of Npt2-/- mice. , 2001, Bone.
[11] K. Miyamoto,et al. Unique uptake and efflux systems of inorganic phosphate in osteoclast-like cells. , 2007, American journal of physiology. Cell physiology.
[12] B. Troen. The Regulation of Cathepsin K Gene Expression , 2006, Annals of the New York Academy of Sciences.
[13] H. Väänänen,et al. Osteoclast Ruffled Border Has Distinct Subdomains for Secretion and Degraded Matrix Uptake , 2003, Traffic.
[14] T. Jentsch,et al. ClC-7 requires Ostm1 as a β-subunit to support bone resorption and lysosomal function , 2006, Nature.
[15] Seoung-Hoon Lee,et al. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). , 2008, Molecular endocrinology.
[16] H. Väänänen,et al. Pharmacological Sequestration of Intracellular Cholesterol in Late Endosomes Disrupts Ruffled Border Formation in Osteoclasts , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] L. Addadi,et al. The molecular dynamics of osteoclast adhesions. , 2006, European journal of cell biology.
[18] D. Mcnulty,et al. Proteolytic Activity of Human Osteoclast Cathepsin K , 1996, The Journal of Biological Chemistry.
[19] P. Schlesinger,et al. Cytoplasmic pH regulation and chloride/bicarbonate exchange in avian osteoclasts. , 1989, The Journal of clinical investigation.
[20] L. Notarangelo,et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis , 2000, Nature Genetics.
[21] D. Barisani,et al. CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts. , 2007, Experimental hematology.
[22] E H Burger,et al. In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes , 1982, The Journal of experimental medicine.
[23] C. Czupalla,et al. Proteomic Analysis of Lysosomal Acid Hydrolases Secreted by Osteoclasts , 2006, Molecular & Cellular Proteomics.
[24] P. Bekker,et al. Biochemical characterization of an electrogenic vacuolar proton pump in purified chicken osteoclast plasma membrane vesicles , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] Sheila J. Jones,et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] D. Veber,et al. Peptide Aldehyde Inhibitors of Cathepsin K Inhibit Bone Resorption Both In Vitro and In Vivo , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[27] K. Miyamoto,et al. Characterization of inorganic phosphate transport in osteoclast-like cells. , 2005, American journal of physiology. Cell physiology.
[28] K. Väänänen,et al. Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption. , 1990, Biochemical and biophysical research communications.
[29] M. Polymeropoulos,et al. A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. , 1996, Genome research.
[30] K. Ohya,et al. Expression of MT1-MMP during deciduous tooth resorption in odontoclasts , 2006, Journal of Bone and Mineral Metabolism.
[31] J. Risteli,et al. Estrogen Reduces the Depth of Resorption Pits by Disturbing the Organic Bone Matrix Degradation Activity of Mature Osteoclasts , 2001 .
[32] R. Kiviranta,et al. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice. , 2007, Bone.
[33] C. Peters,et al. Osteoclastic Bone Degradation and the Role of Different Cysteine Proteinases and Matrix Metalloproteinases: Differences Between Calvaria and Long Bone , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[34] J. Delaissé,et al. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. , 2004, Bone.
[35] Yongwon Choi,et al. v-ATPase V0 subunit d2–deficient mice exhibit impaired osteoclast fusion and increased bone formation , 2006, Nature Medicine.
[36] K. Metsikkö,et al. The architecture of microtubular network and Golgi orientation in osteoclasts--major differences between avian and mammalian species. , 2003, Experimental cell research.
[37] C. Supuran,et al. Membrane-bound carbonic anhydrases in osteoclasts. , 2007, Bone.
[38] E. Génot,et al. CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts. , 2007, Molecular biology of the cell.
[39] K. Väänänen,et al. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics. , 2005, Advanced drug delivery reviews.
[40] Yi Sun,et al. Possible Role of Direct Rac1-Rab7 Interaction in Ruffled Border Formation of Osteoclasts* , 2005, Journal of Biological Chemistry.
[41] K. Väänänen,et al. Organization of osteoclast microfilaments during the attachment to bone surface in vitro , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[42] Yucheng Wang,et al. Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence. , 2007, Human molecular genetics.
[43] I. Kola,et al. Cathepsin K Knockout Mice Develop Osteopetrosis Due to a Deficit in Matrix Degradation but Not Demineralization , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[44] K. Hultenby,et al. Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport. , 2002, Experimental cell research.
[45] S. Teitelbaum,et al. Osteoclastic bone resorption by a polarized vacuolar proton pump. , 1989, Science.
[46] E. Vuorio,et al. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. , 2005, Bone.
[47] S. Morony,et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.
[48] M. Leppilampi,et al. Carbonic anhydrase isoenzymes in isolated rat peripheral monocytes, tissue macrophages, and osteoclasts. , 1987, Bone.
[49] A. Schulz,et al. Loss of the ClC-7 Chloride Channel Leads to Osteopetrosis in Mice and Man , 2001, Cell.
[50] A. Uitterlinden,et al. The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[51] Claus Christiansen,et al. Are Nonresorbing Osteoclasts Sources of Bone Anabolic Activity? , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[52] Yingwei Hu,et al. Inhibition of the osteoclast V‐ATPase by small interfering RNAs , 2005, FEBS letters.
[53] P. Vihko,et al. Intracellular Machinery for Matrix Degradation in Bone‐Resorbing Osteoclasts , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[54] Lynda F. Bonewald,et al. Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts , 2002, The Journal of Biological Chemistry.
[55] R. Luben,et al. Effects of parathormone and calcitonin on citrate and hyaluronate metabolism in cultured bone. , 1976, Endocrinology.
[56] Nathan Nelson,et al. The emerging structure of vacuolar ATPases. , 2006, Physiology.
[57] D. Reid,et al. Polymorphisms of the CLCN7 Gene Are Associated With BMD in Women , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[58] K. Sundquist. Characterization of ATP-dependent proton transport in medullary bone-derived microsomes. , 1993, Bone and mineral.
[59] K. Hultenby,et al. Proteolytic Excision of a Repressive Loop Domain in Tartrate-resistant Acid Phosphatase by Cathepsin K in Osteoclasts* , 2005, Journal of Biological Chemistry.
[60] R. Edwards,et al. Secretion of L‐glutamate from osteoclasts through transcytosis , 2006, The EMBO journal.
[61] C. W. Prince,et al. Roles of hyaluronan in bone resorption , 2004, BMC musculoskeletal disorders.
[62] T. Chambers,et al. Regulation and enzymatic basis of bone resorption by human osteoclasts. , 2007, Clinical science.
[63] H. Väänänen,et al. Potential Function for the ROS‐Generating Activity of TRACP , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[64] B. Samuelsson,et al. Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts. , 2008, Bone.
[65] Hiroaki Nakamura,et al. Transcytosis of calcium from bone by osteoclast-like cells evidenced by direct visualization of calcium in cells. , 2005, Archives of Biochemistry and Biophysics.
[66] Z. Werb,et al. Role of Matrix Metalloproteinase 13 in Both Endochondral and Intramembranous Ossification during Skeletal Regeneration , 2007, PloS one.
[67] H. Väänänen,et al. Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase. , 1994, The Journal of clinical investigation.
[68] V. Parikka,et al. Downregulation of Small GTPase Rab7 Impairs Osteoclast Polarization and Bone Resorption* 210 , 2001, The Journal of Biological Chemistry.
[69] J. Tuukkanen,et al. Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro , 1986, Calcified Tissue International.
[70] K. Väänänen,et al. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[71] A. Ramírez,et al. Identification of a novel mutation in the coding region of the grey‐lethal gene OSTM1 in human malignant infantile osteopetrosis , 2004, Human mutation.
[72] A. Schulz,et al. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. , 2000, Human molecular genetics.
[73] M. Karsdal,et al. The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment. , 2005, Drug news & perspectives.
[74] L. Addadi,et al. The Architecture of the Adhesive Apparatus of Cultured Osteoclasts: From Podosome Formation to Sealing Zone Assembly , 2007, PloS one.
[75] T. Cox,et al. Tartrate‐Resistant Acid Phosphatase Knockout Mice , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[76] Paivi,et al. Calcitonin, prostaglandin E2, and dibutyryl cyclic adenosine 3',5'-monophosphate disperse the specific microfilament structure in resorbing osteoclasts. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[77] M. Eiden,et al. Na+-dependent phosphate transporters in the murine osteoclast: cellular distribution and protein interactions. , 2003, American journal of physiology. Cell physiology.
[78] Yuqiong Liang,et al. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification , 1999, Nature Genetics.
[79] R. Baron,et al. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border , 1985, The Journal of cell biology.
[80] David L. Lacey,et al. Osteoclast differentiation and activation , 2003, Nature.
[81] A. Rinne,et al. Cystatin B as an intracellular modulator of bone resorption. , 2006, Matrix biology : journal of the International Society for Matrix Biology.
[82] P. Schlesinger,et al. Purification of a stilbene sensitive chloride channel and reconstitution of chloride conductivity into phospholipid vesicles. , 1990, Biochemical and biophysical research communications.
[83] H. Väänänen,et al. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. , 2006, Clinical laboratory.